Affiliations 

  • 1 Division of Neurology, Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 2 Department of Neurology, Christian Medical College, Ludhiana, India
  • 3 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • 4 National Cerebral and Cardiovascular Center, Suita, Japan
  • 5 Department of Medicine and Therapeutics, Faculty of Medicine, The Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China
  • 6 Centre for Brain and Cerebral Vessels, Sanno Medical Centre, International University of Health and Welfare, Tokyo, Japan
  • 7 Department of Neurosurgery, Toyama University, Toyama, Japan
  • 8 Chulalongkorn Stroke Centre, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • 9 Department of Medicine, Christian Medical College, Vellore, India
  • 10 Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore, Singapore
  • 11 Raffles Neuroscience Centre, Raffles Hospital, Singapore, Singapore
Cerebrovasc Dis Extra, 2024;14(1):58-75.
PMID: 38657577 DOI: 10.1159/000538928

Abstract

BACKGROUND: There is a significant burden of stroke in Asia. Asia has the largest population in the world in 2023, estimated at 4.7 billion. Approximately 9.5-10.6 million strokes will be anticipated annually in the backdrop of a diverse group of well-developed and less developed countries with large disparities in stroke care resources. In addition, Asian countries are in varying phases of epidemiological transition.

SUMMARY: In this review, we examined recent epidemiological features of ischaemic stroke and intracerebral haemorrhage in Asia with recent developments in hyperacute stroke reperfusion therapy and technical improvements in intracerebral haemorrhage. The article also discussed the spectrum of cerebrovascular diseases in Asia, which include intracranial atherosclerosis, intracerebral haemorrhage, infective aetiologies of stroke, moyamoya disease, vascular dissection, radiation vasculopathy, and cerebral venous thrombosis.

KEY MESSAGES: The review of selected literature and recent updates calls for attention to the different requirements for resources within Asia and highlights the breadth of cerebrovascular diseases still requiring further research and more effective therapies.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.